Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2017 (2017), Article ID 3217474, 6 pages
https://doi.org/10.1155/2017/3217474
Research Article

Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson’s Disease

Department of Neurology and Collaborative Innovation Center for Brain Science, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Correspondence should be addressed to Sheng-Di Chen

Received 9 November 2016; Revised 16 December 2016; Accepted 26 December 2016; Published 24 January 2017

Academic Editor: Hélio Teive

Copyright © 2017 Ya-Chao He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. D. Louis and J. J. Ferreira, “How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor,” Movement Disorders, vol. 25, no. 5, pp. 534–541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-F. Schmouth, P. A. Dion, and G. A. Rouleau, “Genetics of essential tremor: from phenotype to genes, insights from both human and mouse studies,” Progress in Neurobiology, vol. 119-120, pp. 1–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Thenganatt and J. Jankovic, “The relationship between essential tremor and Parkinson's disease,” Parkinsonism and Related Disorders, vol. 22, supplement 1, pp. S162–S165, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Benito-León, E. D. Louis, and F. Bermejo-Pareja, “Risk of incident Parkinson's disease and parkinsonism in essential tremor: A Population Based Study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 4, pp. 423–425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Kalinderi, S. Bostantjopoulou, and L. Fidani, “The genetic background of Parkinson's disease: current progress and future prospects,” Acta Neurologica Scandinavica, vol. 134, no. 5, pp. 314–326, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Funayama, K. Ohe, T. Amo et al., “CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study,” The Lancet Neurology, vol. 14, no. 3, pp. 274–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. K. McDonnell, D. J. Schaid, A. Elbaz et al., “Complex segregation analysis of Parkinson's disease: the Mayo Clinic Family Study,” Annals of Neurology, vol. 59, no. 5, pp. 788–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. N. R. Whaley, J. D. Putzke, Y. Baba, Z. K. Wszolek, and R. J. Uitti, “Essential tremor: phenotypic expression in a clinical cohort,” Parkinsonism and Related Disorders, vol. 13, no. 6, pp. 333–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Wider, O. A. Ross, and Z. K. Wszolek, “Genetics of Parkinson disease and essential tremor,” Current Opinion in Neurology, vol. 23, no. 4, pp. 388–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. X. Chao, E. Y. Ng, L. Tan et al., “Lrrk2 R1628P variant is a risk factor for essential tremor,” Scientific Reports, vol. 5, article 9029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-W. Yu, C.-M. Chen, Y.-C. Chen et al., “SLC1A2 variant is associated with essential tremor in taiwanese population,” PLoS ONE, vol. 8, no. 8, article e71919, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. E. García-Martín, C. Martínez, H. Alonso-Navarro et al., “No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population,” Pharmacogenetics and Genomics, vol. 23, no. 11, pp. 587–590, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. U. Gulsuner, S. Gulsuner, F. N. Mercan et al., “Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 51, pp. 18285–18290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Tzoulis, T. Zayats, P. M. Knappskog et al., “HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 18, Article ID E2268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. X. Chao, E. Y. Ng, J. N. Foo, J. Liu, Y. Zhao, and E.-K. Tan, “Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson disease,” Neurogenetics, vol. 16, no. 3, pp. 241–242, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Hopfner, S. H. Müller, D. Lorenz et al., “Mutations in HTRA2 are not a common cause of familial classic ET,” Movement Disorders, vol. 30, no. 8, pp. 1149–1150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. Postuma, D. Berg, M. Stern et al., “MDS clinical diagnostic criteria for Parkinson's disease,” Movement Disorders, vol. 30, no. 12, pp. 1591–1601, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Deuschl, P. Bain, and M. Brin, “Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee,” Movement Disorders, vol. 13, supplement 3, pp. 2–23, 1998. View at Google Scholar
  19. Z. Li, Z. Zhang, Z. He et al., “A partition-ligation-combination-subdivision em algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio- x.cn),” Cell Research, vol. 19, no. 4, pp. 519–523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Vande Walle, M. Lamkanfi, and P. Vandenabeele, “The mitochondrial serine protease HtrA2/Omi: an overview,” Cell Death and Differentiation, vol. 15, no. 3, pp. 453–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-G. Goo, M. K. Jung, S. S. Han, H. Rhim, and S. Kang, “HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1833, no. 8, pp. 1866–1875, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Plun-Favreau, K. Klupsch, N. Moisoi et al., “The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1,” Nature Cell Biology, vol. 9, no. 11, pp. 1243–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. M. Strauss, L. M. Martins, H. Plun-Favreau et al., “Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease,” Human Molecular Genetics, vol. 14, no. 15, pp. 2099–2111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Jones, P. Datta, S. M. Srinivasula et al., “Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice,” Nature, vol. 425, no. 6959, pp. 721–727, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Bogaerts, K. Nuytemans, J. Reumers et al., “Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease,” Human Mutation, vol. 29, no. 6, pp. 832–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. O. A. Ross, A. I. Soto, C. Vilariño-Güell et al., “Genetic variation of Omi/HtrA2 and Parkinson's disease,” Parkinsonism and Related Disorders, vol. 14, no. 7, pp. 539–543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Simón-Sánchez and A. B. Singleton, “Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls,” Human Molecular Genetics, vol. 17, no. 13, pp. 1988–1993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-H. Lin, M.-L. Chen, G. S. Chen, C.-H. Tai, and R.-M. Wu, “Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria,” Human Genetics, vol. 130, no. 6, pp. 817–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-Y. Wang, Q. Xu, L. Weng et al., “Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease,” Brain Research, vol. 1385, pp. 293–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-Y. Tian, J.-F. Guo, L. Wang et al., “Mutation analysis of LRRK2, SCNA, UCHL1, HtrA2 and GIGYF2 genes in Chinese patients with autosomal dorminant Parkinson's disease,” Neuroscience Letters, vol. 516, no. 2, pp. 207–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-M. Chen, C.-H. Wu, C.-H. Hsieh et al., “HTRA2 variations in Taiwanese Parkinson's disease,” Journal of Neural Transmission, vol. 121, no. 5, pp. 491–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Krüger, M. Sharma, O. Riess et al., “A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease,” Neurobiology of Aging, vol. 32, no. 3, pp. 548.e9–548.e18, 2011. View at Publisher · View at Google Scholar · View at Scopus